Pulse Biosciences Stock Total Asset
| PLSE Stock | USD 19.63 1.84 10.34% |
Pulse Biosciences fundamentals help investors to digest information that contributes to Pulse Biosciences' financial success or failures. It also enables traders to predict the movement of Pulse Stock. The fundamental analysis module provides a way to measure Pulse Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pulse Biosciences stock.
| Last Reported | Projected for Next Year | ||
| Total Assets | 68 M | 49.9 M | |
| Intangibles To Total Assets | 0.09 | 0.09 |
Pulse | Total Asset |
Pulse Biosciences Company Total Asset Analysis
Pulse Biosciences' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Pulse Biosciences Total Asset | 59.15 M |
Most of Pulse Biosciences' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pulse Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pulse Total Asset Driver Correlations
Understanding the fundamental principles of building solid financial models for Pulse Biosciences is extremely important. It helps to project a fair market value of Pulse Stock properly, considering its historical fundamentals such as Total Asset. Since Pulse Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pulse Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pulse Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Pulse Total Asset Historical Pattern
Today, most investors in Pulse Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Pulse Biosciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's total asset growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Pulse Biosciences total asset as a starting point in their analysis.
Pulse Biosciences Total Asset |
| Timeline |
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
| Competition |
Pulse Total Assets
Total Assets |
|
Based on the latest financial disclosure, Pulse Biosciences has a Total Asset of 59.15 M. This is 99.21% lower than that of the Health Care Equipment & Supplies sector and 98.21% lower than that of the Health Care industry. The total asset for all United States stocks is 99.8% higher than that of the company.
Pulse Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulse Biosciences' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulse Biosciences could also be used in its relative valuation, which is a method of valuing Pulse Biosciences by comparing valuation metrics of similar companies.Pulse Biosciences is currently under evaluation in total asset category among its peers.
Pulse Biosciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Pulse Biosciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Pulse Biosciences' managers, analysts, and investors.Environmental | Governance | Social |
Pulse Biosciences Institutional Holders
Institutional Holdings refers to the ownership stake in Pulse Biosciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Pulse Biosciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Pulse Biosciences' value.| Shares | Westside Investment Management, Inc. | 2024-09-30 | 55 K | Bank Of New York Mellon Corp | 2024-09-30 | 40.3 K | Spotlight Asset Group, Inc. | 2024-06-30 | 40.3 K | Swiss National Bank | 2024-09-30 | 35.9 K | Goldman Sachs Group Inc | 2024-09-30 | 35.7 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 33.5 K | Barclays Plc | 2024-09-30 | 30.3 K | Tiaa Trust National Association | 2024-09-30 | 27.3 K | Rhumbline Advisers | 2024-09-30 | 25.8 K | Blackrock Inc | 2024-09-30 | 1.3 M | Vanguard Group Inc | 2024-09-30 | 995.8 K |
Pulse Fundamentals
| Return On Equity | -0.7 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 1.14 B | ||||
| Shares Outstanding | 61.52 M | ||||
| Shares Owned By Insiders | 71.93 % | ||||
| Shares Owned By Institutions | 9.31 % | ||||
| Number Of Shares Shorted | 2.17 M | ||||
| Price To Earning | (22.54) X | ||||
| Price To Book | 15.26 X | ||||
| Price To Sales | 60.23 X | ||||
| Revenue | (9 K) | ||||
| Gross Profit | (550 K) | ||||
| EBITDA | (42.37 M) | ||||
| Net Income | (42.21 M) | ||||
| Cash And Equivalents | 14.8 M | ||||
| Cash Per Share | 0.40 X | ||||
| Total Debt | 9.14 M | ||||
| Debt To Equity | 0.45 % | ||||
| Current Ratio | 3.14 X | ||||
| Book Value Per Share | 1.29 X | ||||
| Cash Flow From Operations | (33.04 M) | ||||
| Short Ratio | 21.18 X | ||||
| Earnings Per Share | (0.82) X | ||||
| Target Price | 5.0 | ||||
| Number Of Employees | 56 | ||||
| Beta | 1.75 | ||||
| Market Capitalization | 992.88 M | ||||
| Total Asset | 59.15 M | ||||
| Retained Earnings | (336.92 M) | ||||
| Working Capital | 38.62 M | ||||
| Current Asset | 4 M | ||||
| Current Liabilities | 660 K | ||||
| Net Asset | 59.15 M |
About Pulse Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pulse Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulse Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulse Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Pulse Biosciences Piotroski F Score and Pulse Biosciences Altman Z Score analysis. For information on how to trade Pulse Stock refer to our How to Trade Pulse Stock guide.You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulse Biosciences. If investors know Pulse will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulse Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulse Biosciences is measured differently than its book value, which is the value of Pulse that is recorded on the company's balance sheet. Investors also form their own opinion of Pulse Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Pulse Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulse Biosciences' market value can be influenced by many factors that don't directly affect Pulse Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulse Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulse Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulse Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.